Nueraccel Biosciences entered the industry of Pharmaceutical Research Laboratories in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417112, which describes it as a Pharmaceutical Research Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Pharmaceutical Research Laboratories. The business provides service to the B2B market.
To acquire more information, please contact by calling (858) 457-8128 during business hours. You can also write to the business’ Single Location at 11099 North Torrey Pines Road, San Diego, California CA 92121. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Nueraccel Biosciences |
| Place of Business: | 11099 North Torrey Pines Road, San Diego, CA 92121 |
| Contact Number: | (858) 457-8128 |
| Type of Service: | Pharmaceutical Research Laboratories |
| SIC Number: | 8731 |
| NAICS Number: | 5417112 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Nueraccel Biosciences is a company operating from San Diego, California providing professional Pharmaceutical Research Laboratories and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Pharmaceutical Research Laboratories, and with the NAICS code 5417112 as Pharmaceutical Research Laboratories.
With a current employee count of 1 to 4, Nueraccel Biosciences has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative at (858) 457-8128 for related queries, or to locate its Single Location using the coordinates 32.89319,-117.19457.
The Single Location can also be found at the street address 11099 North Torrey Pines Road in San Diego, California 92121 and can be engaged online through the company website at , the company Twitter , and Facebook page .